Our Team

Deep expertise in fusion protein engineering & synthetic biology

Decades of experience in biotechnology, drug development, and company creation

Jeffrey C. Way, PhD

President & CEO

Merck KGaA/EMD: >10 years
Extensive knowledge of protein and DNA engineering
Harvard Ph.D., B.A.

R. Rogers Yocum, PhD

Chief Scientific Officer

Over 30 years in the biotech industry
Founder experience: BioTechnica (IPO’ed 1983)
Harvard Ph.D., post-doc

Pamela A. Silver, PhD

Founder, Scientific Advisor

Prof of Biochemistry & Systems Biology at Harvard Medical School
Founder and Director, SynBio Hive
Cofounder of Karyopharm Therapeutics

Learn More:

Katherine Redfield Chan, MD

Medical Advisor

Anesthesiology Resident at Brigham and Women's Hospital
Graduate Student Researcher - Protein Engineering and Synthetic Biology at Harvard University